Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Moss

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Clinical Pathology|March 1, 1989
Observer variability in histopathological reporting of cervical biopsy specimensA J Robertson, J M Anderson, J S Beck, et al.
Journal of Clinical Pathology|January 1, 1994
Observer variability in the histopathological reporting of abnormal rectal biopsy specimensA M Lessells, J S Beck, R A Burnett, et al.
Journal of Clinical Pathology|January 1, 1990
Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladdersA J Robertson, J S Beck, R A Burnett, et al.
Endoscopy|December 21, 2012
Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in EnglandT J W Lee, R G Blanks, C J Rees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusionJ A Sosman, P Stiff, S M Moss, et al.
British Journal of Cancer|November 27, 2001
Routine breast screening for women aged 65-69: results from evaluation of the demonstration sitesS M Moss, J Brown, L Garvican, et al.
Lancet (London, England)|May 25, 2005
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)M O Leach, C R M Boggis, A K Dixon, et al.
British Journal of Cancer|October 4, 2006
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancerI Griebsch, J Brown, C Boggis, et al.
Journal of the National Cancer Institute|December 16, 2014
Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC dataE A M Heijnsdijk, T M de Carvalho, A Auvinen, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancerJ Brown, A Coulthard, A K Dixon, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Clinical Pathology|March 1, 1989
Observer variability in histopathological reporting of cervical biopsy specimensA J Robertson, J M Anderson, J S Beck, et al.
Journal of Clinical Pathology|January 1, 1994
Observer variability in the histopathological reporting of abnormal rectal biopsy specimensA M Lessells, J S Beck, R A Burnett, et al.
Journal of Clinical Pathology|January 1, 1990
Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladdersA J Robertson, J S Beck, R A Burnett, et al.
Endoscopy|December 21, 2012
Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in EnglandT J W Lee, R G Blanks, C J Rees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusionJ A Sosman, P Stiff, S M Moss, et al.
British Journal of Cancer|November 27, 2001
Routine breast screening for women aged 65-69: results from evaluation of the demonstration sitesS M Moss, J Brown, L Garvican, et al.
Lancet (London, England)|May 25, 2005
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)M O Leach, C R M Boggis, A K Dixon, et al.
British Journal of Cancer|October 4, 2006
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancerI Griebsch, J Brown, C Boggis, et al.
Journal of the National Cancer Institute|December 16, 2014
Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC dataE A M Heijnsdijk, T M de Carvalho, A Auvinen, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancerJ Brown, A Coulthard, A K Dixon, et al.
Pageof 10